Drugs / DA-3801
last change Oct 2012 re-read 2 minutes ago

DA-3801

Protein / enzyme biologic

Developed for
anovulation · infertility disorder
Investigated by
Dong-A ST Co., Ltd.

Trials 1 · a red edge is where a trial was stopped

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01820728 Jan 2007 → Oct 2012 anovulation, infertility disorder Dong-A ST Co., Ltd. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DA-3801 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01820728
Modality Protein / enzyme biologic “Recominant human follicle stimulating hormone 75 IU/day is injected for 14 days” NCT01820728